- ORCID iD
- 0000-0002-1752-6821
Show
Sort by
-
Personalized medicine in metastatic prostate cancer
(2023) -
Multicentric prospective local treatment of metastatic prostate cancer (LoMP) study
-
- Journal Article
- A1
- open access
The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry
-
Androgen receptor expression in preputial dartos tissue correlates with physiological androgen exposure in congenital malformations of the penis and in controls
-
- Journal Article
- A1
- open access
Primary versus redo urethroplasty : results from a single-center comparative analysis
-
Tracking the origins of metastatic seeding in de novo metastatic prostate cancer
-
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma : results from three high-volume robotic surgery institutions
-
Castration-resistant prostate cancer-free survival in the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial
-
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time
-
Abiraterone and spironolactone in prostate cancer : a combination to avoid
-
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
-
Prospective randomized controlled trial exploring the effect of TachoSil on lymphocele formation after extended pelvic lymph node dissection in prostate cancer
-
MRI in prostate cancer diagnosis, surgical or radiation treatment, focal therapy, active surveillance and follow-up
-
- Conference Paper
- C3
- open access
Robot-geassisteerde nefro-ureterectomie voor urotheelCa van de hogere urinewegen : resultaten van 3 high-volume robot centra
-
Multicentric prospective local treatment of metastatic prostate cancer (LOMP) trial : interim analysis of clinical outcomes and prognostic factors
-
Reproducible isolation of high-purity urinary extracellular vesicles for uro-oncological biomarker studies
-
Multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial : interim analysis of clinical outcomes and prognostic factors
-
Reproducible high-purity isolation of urinary extracellular vesicles for uro-oncological biomarker studies
-
Prognostische significantie van metastatische symptomen bij nieuw gediagnosticeerd prostaatkanker
-
Multicentrische prospectieve Lokale behandeling van Metastatische Prostaatkanker (LoMP) studie : interim analyse van de klinische uitkomsten en prognostische factoren